Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter.
Kamat AM, Lobo N, Lerner SP, Li R, Matulay JT, Palou J, Witjes JA, Rouprêt M, Smith AB, Chang SS, Shore ND, Steinberg GD, Dinney CP, Svatek RS, Lamm DL. Kamat AM, et al. Among authors: smith ab. Bladder Cancer. 2022 Jun 3;8(2):113-117. doi: 10.3233/BLC-211648. eCollection 2022. Bladder Cancer. 2022. PMID: 38993360 Free PMC article.
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.
Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y. Apolo AB, et al. Among authors: smith ab. Urol Oncol. 2015 Feb;33(2):53-64. doi: 10.1016/j.urolonc.2014.06.013. Epub 2014 Jul 25. Urol Oncol. 2015. PMID: 25065704 Free PMC article. Review.
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study.
Smith AB, Daneshmand S, Patel S, Pohar K, Trabulsi E, Woods M, Downs T, Huang W, Taylor J, Jones J, O'Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety B, Schoenberg M, Jones JS, Lotan Y; Flexible Blue Light Study Group Collaborators. Smith AB, et al. BJU Int. 2019 Jan;123(1):35-41. doi: 10.1111/bju.14481. Epub 2018 Aug 11. BJU Int. 2019. PMID: 29979488 Clinical Trial.
Quality Indicators for Bladder Cancer Services: A Collaborative Review.
Leow JJ, Catto JWF, Efstathiou JA, Gore JL, Hussein AA, Shariat SF, Smith AB, Weizer AZ, Wirth M, Witjes JA, Trinh QD. Leow JJ, et al. Among authors: smith ab. Eur Urol. 2020 Jul;78(1):43-59. doi: 10.1016/j.eururo.2019.09.001. Epub 2019 Sep 26. Eur Urol. 2020. PMID: 31563501 Free article.
Quality of Bladder Cancer Information on YouTube.
Loeb S, Reines K, Abu-Salha Y, French W, Butaney M, Macaluso JN Jr, Steinberg GD, Walter D, Byrne N, la Garza D, Smith AB. Loeb S, et al. Among authors: smith ab. Eur Urol. 2021 Jan;79(1):56-59. doi: 10.1016/j.eururo.2020.09.014. Epub 2020 Oct 1. Eur Urol. 2021. PMID: 33010986
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.
Shabsigh A, Kleinmann N, Smith AB, Scherr D, Seltzer E, Schoenberg M, Lerner SP. Shabsigh A, et al. Among authors: smith ab. Cancer Chemother Pharmacol. 2021 Jun;87(6):799-805. doi: 10.1007/s00280-021-04246-w. Epub 2021 Mar 7. Cancer Chemother Pharmacol. 2021. PMID: 33677615 Free PMC article. Clinical Trial.
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
Chevli KK, Shore ND, Trainer A, Smith AB, Saltzstein D, Ehrlich Y, Raman JD, Friedman B, D'Anna R, Morris D, Hu B, Tyson M, Sankin A, Kates M, Linehan J, Scherr D, Kester S, Verni M, Chamie K, Karsh L, Cinman A, Meads A, Lahiri S, Malinowski M, Gabai N, Raju S, Schoenberg M, Seltzer E, Huang WC. Chevli KK, et al. Among authors: smith ab. J Urol. 2022 Jan;207(1):61-69. doi: 10.1097/JU.0000000000002186. Epub 2021 Aug 26. J Urol. 2022. PMID: 34433303 Free PMC article. Clinical Trial.
Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis.
Russo GI, Sholklapper TN, Cocci A, Broggi G, Caltabiano R, Smith AB, Lotan Y, Morgia G, Kamat AM, Witjes JA, Daneshmand S, Desai MM, Gill IS, Cacciamani GE. Russo GI, et al. Among authors: smith ab. Cancers (Basel). 2021 Aug 30;13(17):4378. doi: 10.3390/cancers13174378. Cancers (Basel). 2021. PMID: 34503188 Free PMC article. Review.
Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer.
Gore JL, Wolff EM, Comstock BA, Follmer KM, Nash MG, Basu A, Chisolm S, MacLean DB, Lee JR, Lotan Y, Porten SP, Steinberg GD, Chang SS, Gilbert SM, Kessler LG, Smith AB; CISTO Collaborative. Gore JL, et al. Among authors: smith ab. BMC Cancer. 2023 Nov 18;23(1):1127. doi: 10.1186/s12885-023-11605-8. BMC Cancer. 2023. PMID: 37980511 Free PMC article.
1,269 results